TCTR20230908007尚未招募不适用
Alteration of Gut Microbiota in Patients with Advanced Hepatocellular carcinoma: A Cross-sectional Analytical Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Patients aged more than 18 years old diagnosed with advanced hepatocellular carcinoma.
- •2. No other concomittent malignancy, or cured for more than 5 years.
- •3. Born in the northeastern part of Thailand
排除标准
- •1. Patients who diagnosed with Hepatocellular cholangiocarcinoma
- •2. Current users of drug/substanced affected to gut microbiota or history of use within 14 days e.g. antibiotics , proton pump inhibitor, probiotics product, Ursodeoxycholic Acid
- •3. Have specific eating pattern
- •4. Cannot obtain fecal sample or not enough sample for analysis
研究者
相似试验
已完成
不适用
Alterations of the gut microbiome in patients with IBS in correlation to illness anxiety and symptom severityK58F45.32Irritable bowel syndromeDRKS00033141niversitätsklinikum Heidelberg, Abteilung für Allgemeine Innere Medizin und Psychosomatik70
招募中
不适用
Investigation of the gut microbiome in patients with head and neck cancer (HNSCC) and analysis of the prognostic potential of response and tolerability of PD-1, PDL-1 immune checkpoint inhibitors in head and neck cancerhead and neck carcinomaDRKS00032481ehrstuhl für Hals-Nasen-Ohrenheilkunde Universität Witten/Herdecke50
招募中
不适用
Characterization of gut microbiome in patients with lung adenocarcinomalung adenocarcinomaJPRN-UMIN000040543Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine50
招募中
不适用
Analysis of the gut microbiome of patients with rare monogenic metabolic diseasesRare monogenic metabolic diseasesDRKS00033718niversitätsklinikum Heidelberg500
进行中（未招募）
Unknown
Evaluation of the pattern of gut bacteria in patients with type 2 Diabetes Mellitus using the drug SemaglutideType 2 Diabetes MellitusRBR-5xhygvdniversidade Estadual de Campinas